These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 26537928

  • 41. Tip variant of focal segmental glomerulosclerosis: outcome and comparison to 'not otherwise specified' variant.
    Arias LF, Franco-Alzate C, Rojas SL.
    Nephrol Dial Transplant; 2011 Jul; 26(7):2215-21. PubMed ID: 21068139
    [Abstract] [Full Text] [Related]

  • 42. Clinical course of primary focal segmental glomerulosclerosis (FSGS) in Turkish children: a report from the Turkish Pediatric Nephrology FSGS Study Group.
    Beşbaş N, Ozaltin F, Emre S, Anarat A, Alpay H, Bakkaloğlu A, Baskin E, Buyan N, Dönmez O, Düşünsel R, Ekim M, Göko F, Gür-Güven A, Kavukçu S, Mir S, Sönmez F.
    Turk J Pediatr; 2010 Jul; 52(3):255-61. PubMed ID: 20718182
    [Abstract] [Full Text] [Related]

  • 43. CD80, suPAR and nephrotic syndrome in a case of NPHS2 mutation.
    Cara-Fuentes G, Araya C, Wei C, Rivard C, Ishimoto T, Reiser J, Johnson RJ, Garin EH.
    Nefrologia; 2013 Jul; 33(5):727-31. PubMed ID: 24089165
    [Abstract] [Full Text] [Related]

  • 44. FSGS: Diagnosis and Diagnostic Work-Up.
    Sprangers B, Meijers B, Appel G.
    Biomed Res Int; 2016 Jul; 2016():4632768. PubMed ID: 27314022
    [Abstract] [Full Text] [Related]

  • 45. [Long-term monitoring of children with focal segmental glomerulosclerosis and a transplanted kidney].
    Seso Simić D, Slavicek J, Bubić Filipi L, Puretić Z, Kes P.
    Acta Med Croatica; 2003 Jul; 57(1):53-6. PubMed ID: 12876864
    [Abstract] [Full Text] [Related]

  • 46. Podocalyxin-positive glomerular epithelial cells in urine correlate with a positive outcome in FSGS.
    Mueller-Deile J, Kümpers P, Achenbach J, Park JK, Mengel M, Haller H, Schiffer M.
    J Nephrol; 2012 Jul; 25(5):802-9. PubMed ID: 22241637
    [Abstract] [Full Text] [Related]

  • 47. THE METABOLOMICS SIGNATURE ASSOCIATED WITH RESPONSIVENESS TO STEROID THERAPY IN FOCAL SEGMENTAL GLOMERULOSCLEROSIS: A PILOT STUDY.
    Chashmniam S, Kalantari S, Nafar M, Boroumandnia N.
    Rev Invest Clin; 2019 Jul; 71(2):106-115. PubMed ID: 31056594
    [Abstract] [Full Text] [Related]

  • 48. Comparison of Glomerular Transcriptome Profiles of Adult-Onset Steroid Sensitive Focal Segmental Glomerulosclerosis and Minimal Change Disease.
    Tong J, Xie J, Ren H, Liu J, Zhang W, Wei C, Xu J, Zhang W, Li X, Wang W, Lv D, He JC, Chen N.
    PLoS One; 2015 Jul; 10(11):e0140453. PubMed ID: 26536600
    [Abstract] [Full Text] [Related]

  • 49. Secondary Focal Segmental Glomerulosclerosis: From Podocyte Injury to Glomerulosclerosis.
    Kim JS, Han BG, Choi SO, Cha SK.
    Biomed Res Int; 2016 Jul; 2016():1630365. PubMed ID: 27088082
    [Abstract] [Full Text] [Related]

  • 50. Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States.
    Kitiyakara C, Eggers P, Kopp JB.
    Am J Kidney Dis; 2004 Nov; 44(5):815-25. PubMed ID: 15492947
    [Abstract] [Full Text] [Related]

  • 51. Potential biomarkers of recurrent FSGS: a review.
    Hou S, Yang B, Chen Q, Xu Y, Li H.
    BMC Nephrol; 2024 Aug 12; 25(1):258. PubMed ID: 39134955
    [Abstract] [Full Text] [Related]

  • 52. MCP1 2518 A/G polymorphism affects progression of childhood focal segmental glomerulosclerosis.
    Besbas N, Kalyoncu M, Cil O, Ozgul RK, Bakkaloglu A, Ozaltin F.
    Ren Fail; 2015 Aug 12; 37(9):1435-9. PubMed ID: 26335292
    [Abstract] [Full Text] [Related]

  • 53. [Nephrotic syndrom with focal and segmental glomerulosclerosis in Dakar: epidemiological and clinicopathological characteristics (about 134 cases)].
    Niang A, Dial C, Ka EF, Lèye A, Pouye A, Ka MM, Mbengue M, Droz D, Diouf B.
    Dakar Med; 2008 Aug 12; 53(1):45-51. PubMed ID: 19102117
    [Abstract] [Full Text] [Related]

  • 54. Podocyte and endothelial injury in focal segmental glomerulosclerosis: an ultrastructural analysis.
    Taneda S, Honda K, Ohno M, Uchida K, Nitta K, Oda H.
    Virchows Arch; 2015 Oct 12; 467(4):449-58. PubMed ID: 26266776
    [Abstract] [Full Text] [Related]

  • 55. Review on diagnosis and treatment of focal segmental glomerulosclerosis.
    Deegens JK, Steenbergen EJ, Wetzels JF.
    Neth J Med; 2008 Jan 12; 66(1):3-12. PubMed ID: 18219061
    [Abstract] [Full Text] [Related]

  • 56. [Study of urinary markers of different podocytopathies by proteomic analysis].
    Vinogradov AA, Chebotareva NV, Bugrova AE, Brzhozovskiy AG, Krasnova TN, Nasibullina KZ, Kononikhin AS, Moiseev SV.
    Ter Arkh; 2023 Aug 17; 95(6):457-461. PubMed ID: 38158963
    [Abstract] [Full Text] [Related]

  • 57. Low birthweight and premature birth are risk factors for podocytopenia and focal segmental glomerulosclerosis.
    Ikezumi Y, Suzuki T, Karasawa T, Yamada T, Hasegawa H, Nishimura H, Uchiyama M.
    Am J Nephrol; 2013 Aug 17; 38(2):149-57. PubMed ID: 23920104
    [Abstract] [Full Text] [Related]

  • 58. Proteomic profile‑based screening of potential protein biomarkers in the urine of patients with nephrotic syndrome.
    Wang Y, Zheng C, Wang X, Zuo K, Liu Z.
    Mol Med Rep; 2017 Nov 17; 16(5):6276-6284. PubMed ID: 28849145
    [Abstract] [Full Text] [Related]

  • 59. Ultrastructural features and expression of cytoskeleton proteins of podocyte from patients with minimal change disease and focal segmental glomerulosclerosis.
    Shi SF, Wang SX, Zhang YK, Zhao MH, Zou WZ.
    Ren Fail; 2008 Nov 17; 30(5):477-83. PubMed ID: 18569926
    [Abstract] [Full Text] [Related]

  • 60. Distinct metabolic profile of primary focal segmental glomerulosclerosis revealed by NMR-based metabolomics.
    Hao X, Liu X, Wang W, Ren H, Xie J, Shen P, Lin D, Chen N.
    PLoS One; 2013 Nov 17; 8(11):e78531. PubMed ID: 24244321
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.